FDA’s Informed Consent Change Is Step Toward Harmonizing: And what about the revised Common Rule?


    loading  Checking for direct PDF access through Ovid

Abstract

The FDA’s recent move to allow a waiver of informed consent for studies involving minimal risk could be a first step toward harmonization with the existing Common Rule.

    loading  Loading Related Articles